Timothy T. Chole
Corporate Officer/Principal at ROCKWELL MEDICAL, INC.
Net worth: 45 170 $ as of 2024-06-29
Profile
Timothy T.
Chole is currently the Chief Commercial Officer at Rockwell Medical, Inc. He previously worked as the Marketing Director at Gambro AB and as the Director-Product Marketing at Cochlear Americas.
Mr. Chole completed his undergraduate degree at the University of California.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ROCKWELL MEDICAL, INC.
0.08% | 2024-05-20 | 25,665 ( 0.08% ) | 45 170 $ | 2024-06-29 |
Timothy T. Chole active positions
| Companies | Position | Start |
|---|---|---|
| ROCKWELL MEDICAL, INC. | Corporate Officer/Principal | 2024-05-29 |
Former positions of Timothy T. Chole
| Companies | Position | End |
|---|---|---|
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Sales & Marketing | 2013-09-30 |
| Cochlear Americas | Corporate Officer/Principal | - |
Training of Timothy T. Chole
| University of California | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ROCKWELL MEDICAL, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Gambro AB
Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Health Technology |
| Cochlear Americas |
- Stock Market
- Insiders
- Timothy T. Chole
